Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Enasidenib Drugs Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Enasidenib Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 50mg
      • 1.3.3 100mg
    • 1.4 Market Segment by Application
      • 1.4.1 Global Enasidenib Drugs Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Pharmacy
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Enasidenib Drugs Market Size
      • 2.1.1 Global Enasidenib Drugs Revenue 2014-2025
      • 2.1.2 Global Enasidenib Drugs Sales 2014-2025
    • 2.2 Enasidenib Drugs Growth Rate by Regions
      • 2.2.1 Global Enasidenib Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Enasidenib Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Enasidenib Drugs Sales by Manufacturers
      • 3.1.1 Enasidenib Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Enasidenib Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Enasidenib Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Enasidenib Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Enasidenib Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Enasidenib Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Enasidenib Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Enasidenib Drugs Market
    • 3.6 Key Manufacturers Enasidenib Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 50mg Sales and Revenue (2014-2019)
      • 4.1.2 100mg Sales and Revenue (2014-2019)
    • 4.2 Global Enasidenib Drugs Sales Market Share by Type
    • 4.3 Global Enasidenib Drugs Revenue Market Share by Type
    • 4.4 Enasidenib Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Enasidenib Drugs Sales by Application

    6 United States

    • 6.1 United States Enasidenib Drugs Breakdown Data by Company
    • 6.2 United States Enasidenib Drugs Breakdown Data by Type
    • 6.3 United States Enasidenib Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Enasidenib Drugs Breakdown Data by Company
    • 7.2 European Union Enasidenib Drugs Breakdown Data by Type
    • 7.3 European Union Enasidenib Drugs Breakdown Data by Application

    8 China

    • 8.1 China Enasidenib Drugs Breakdown Data by Company
    • 8.2 China Enasidenib Drugs Breakdown Data by Type
    • 8.3 China Enasidenib Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Enasidenib Drugs Breakdown Data by Company
    • 9.2 Rest of World Enasidenib Drugs Breakdown Data by Type
    • 9.3 Rest of World Enasidenib Drugs Breakdown Data by Application
    • 9.4 Rest of World Enasidenib Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Enasidenib Drugs Sales by Countries
      • 9.4.2 Rest of World Enasidenib Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Celgene Corporation
      • 10.1.1 Celgene Corporation Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Enasidenib Drugs
      • 10.1.4 Enasidenib Drugs Product Introduction
      • 10.1.5 Celgene Corporation Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Enasidenib Drugs Sales Channels
      • 11.2.2 Enasidenib Drugs Distributors
    • 11.3 Enasidenib Drugs Customers

    12 Market Forecast

    • 12.1 Global Enasidenib Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Enasidenib Drugs Sales Forecast by Type
    • 12.3 Global Enasidenib Drugs Sales Forecast by Application
    • 12.4 Enasidenib Drugs Forecast by Regions
      • 12.4.1 Global Enasidenib Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Enasidenib Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
      In 2019, the market size of Enasidenib Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Enasidenib Drugs.

      This report studies the global market size of Enasidenib Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Enasidenib Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Celgene Corporation
      ...

      Market Segment by Product Type
      50mg
      100mg

      Market Segment by Application
      Hospital
      Pharmacy

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Enasidenib Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Enasidenib Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Enasidenib Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now